Although the biochemical response represented by a reduction of CRP during follow‐up did not reach statistical significance, we observed a significant reduction of HBI and an almost total discontinuation of steroids at the end of follow‐up.
← all excerpts
Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseases.
1
—
—